COMBINED HYPERLIPIDAEMIA

This adverse event was reported 1 times

COMBINED HYPERLIPIDAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DROSPIRENONE AND ESTRADIOL 1 0.0019
1 FEXOFENADINE HCL 1 0.0003
2 CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE 1 0.0000
3 ANASTROZOLE 1 0.0000
4 ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL 1 0.0000
5 IRON 1 0.0000
6 MONTELUKAST SODIUM 1 0.0000
7 FLUTICASONE PROPIONATE 1 0.0000
8 ZOLPIDEM TARTRATE 1 0.0000
9 CETIRIZINE HYDROCHLORIDE 1 0.0000
See all drugs enriched for association with COMBINED HYPERLIPIDAEMIA

These drug classes are most commonly taken by patients reporting COMBINED HYPERLIPIDAEMIA:

# Drug class Count
0 Aromatase Inhibitor [EPC] 1
1 Estrogen [EPC] 1
2 HMG-CoA Reductase Inhibitor [EPC] 1
3 Progestin [EPC] 1
See all common drug classes associated with COMBINED HYPERLIPIDAEMIA

COMBINED HYPERLIPIDAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Aromatase Inhibitor [EPC] 1 0.0000
1 Estrogen [EPC] 1 0.0000
2 Progestin [EPC] 1 0.0000
3 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with COMBINED HYPERLIPIDAEMIA